TABLE 1.
Investigations prior to panenteric capsule endoscopy
| n (%) | |
|---|---|
| Suspected Crohn's disease | 22 (23.7) |
| Previous endoscopy | |
| Complete colonoscopy | 10 (45.5) |
| Incomplete colonoscopy | 6 (27.3) |
| No previous endoscopy | 6 (27.3) |
| Established Crohn's disease | 71 (76.3) |
| Previous investigations | |
| Ileocolonoscopy | 51 (71.8) |
| Colonoscopy | 11 (15.5) |
| CE | 19 (26.8) |
| MRI | 30 (42.3) |
| CTE | 16 (22.5) |
| BaFT | 3 (4.2) |
| Colonoscopy alone | 22 (30.1) |
| Colonoscopy and SB investigations | 19 (26.8) |
| SB investigations alone | 28 (39.4) |
| Unknown | 2 (2.8) |
| Had treatment between last assessment and panenteric capsule endoscopy n,(%) Yes | 30 (42.3) |
| Biologics | 20 (28.2) |
| Immunomodulators | 14 (19.7) |
| Surgery | 1 (1.4) |
Abbreviations: BaFT, barium follow through; CE, capsule endoscopy; CTE, computed tomography enterography; MRI, magnetic resonance imaging.